A phase 1/2 trial to evaluate the pharmacokinetics, safety, and efficacy of NI-03 in patients with chronic pancreatitis: study protocol for a randomized controlled trial on the assessment of camostat treatment in chronic pancreatitis (TACTIC)

BACKGROUND: Chronic pancreatitis (CP) is a progressive, fibro-inflammatory disease characterized by enzymatic autoactivation and subsequent fibrotic replacement of acinar cells. A significant proportion of patients develop pain, which may be due to many causes, including perineural inflammation, alt...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramsey, Mitchell L., Nuttall, Janet, Hart, Phil A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6694471/
https://www.ncbi.nlm.nih.gov/pubmed/31412955
http://dx.doi.org/10.1186/s13063-019-3606-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6694471/
https://www.ncbi.nlm.nih.gov/pubmed/31412955
http://dx.doi.org/10.1186/s13063-019-3606-y

Ejemplares similares